Does IL-23/Th17 activation drive intestinal inflammation, barrier loss, and visceral pain?

The IL-23/Th17 immune axis is established as a central regulator of intestinal homeostasis, where its chronic activation shifts from a protective role to a primary driver of pathology and sensory dysfunction.

Clinical and Mechanistic Evidence

Research highlights the IL-23/Th17 pathway as a critical driver of chronic intestinal inflammation, particularly in inflammatory bowel disease (IBD). Interleukin-23 (IL-23) promotes the differentiation of pathogenic Th17 cells, which secrete pro-inflammatory cytokines such as IL-17A. These cytokines directly impair the intestinal barrier by downregulating and mislocalizing essential tight junction proteins, including occludin, zonula occludens-1 (ZO-1), and claudin-4. This molecular breakdown results in increased epithelial permeability, often quantified in research models by elevated FITC-dextran leakage. Clinical evidence reinforces this: genetic variants that reduce IL-23 receptor function significantly lower the risk for Crohn's disease and ulcerative colitis.

Neuroimmune Pain Signaling

The disruption of the intestinal barrier initiates a feedback loop that perpetuates visceral pain. Increased permeability allows luminal antigens to translocate into the lamina propria, where they trigger the degranulation of mast cells. This process releases a range of neuroactive mediators:

• Pro-inflammatory factors: Histamine, prostaglandin E2 (PGE2), and various cytokines.
• Nociceptor Sensitization: These mediators activate and sensitize sensory neurons by targeting receptors such as TRPV1, EP2, and PAR2.
• Neural Amplification: This sensitization lowers the threshold for pain signals, leading to visceral hypersensitivity.

Furthermore, enteric glia respond to these inflammatory cues by releasing additional PGE2 and IL-1β, creating a self-sustaining environment of neuroinflammation and abdominal discomfort.

Bottom line

The IL-23/Th17 pathway promotes intestinal inflammation and barrier disruption, which in turn facilitates the translocation of antigens and the release of immune mediators that sensitize pain-sensing neurons. This sequence provides a robust mechanistic explanation for the link between immune activation and persistent visceral pain.